A clinically advanced Innovative pharmaceutical R&D group with international competitiveness
Committed to the development and commercialization of drugs that meet clinical needs and are accessible to patients. The group has two major R&D centers, with a total area of nearly 9,000m², located in the core areas of Zhangjiang in Shanghai and the Industrial Park in Suzhou. Additionally,have invested in and built a 55-acre industrial base in the Lifescience Bay area of Lingang for industrialization purposes. The group has a pipeline of nearly 20 new drug development projects, with a particular focus on the three core therapeutic areas of orthopedics, oncology, and neuroscience, as well as dedicated research investment in the field of small nucleic acids.”